CTIM-26. PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL

Authors: Daniela Bota, David Piccioni, R LaRocca, Christopher Duma, Santosh Kesari, Jose Carrillo, Robert T O’Donnell, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Candace Hsieh, Chris Langford, Krystal Carta, Adrienne Wang, James Langford, Thomas Taylor, Gabriel Nistor, Robert Dillman

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa215.160

Source: Full article

CTIM-26. PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL

Abstract